Clinical Trial Update: Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of combining L-Arabinose with indigestible dextrin on obesity. The study was sponsored by Hiroshima University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Indigestible Dextrin (indigestible dextrin)
• L-Arabinose (L-arabinose)

Snippet

Sponsor: Hiroshima University | Conditions: Obesity | NA | Status: COMPLETED